3rd Quarter - Report
RK STRATEGIES, INC. for NEUROTHERA LABS, INC.
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA Issues involving Orphan Drug Designation
Foreign entity interest: NeuroThera Inc. and its affiliate SciSparc Ltd are Canadian/Israeli companies with U.S. operations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RYAN KANE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.